Analyst firms · Raymond James · AVAH

Raymond James AVAH price target and rating history

Aveanna Healthcare Holdings Inc. (AVAH) · Health Care

Raymond James rates Aveanna Healthcare Holdings Inc. (AVAH) Strong Buy with a $13 price target, as of its latest action on Mar 20, 2026. It has published 3 rating actions on AVAH since November 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a AVAH price target in the last 12 months, the median target is $11. Raymond James's $13 is 18% above that.

Current rating
Strong Buy
Price target
$13
Median target, all firms
$11
Actions on AVAH
3

Raymond James price target on AVAH

$13$13$1220222023202420252026
Raymond James price target on AVAH, each point a stated target, November 2021 to March 2026.

Every Raymond James rating on AVAH

How other firms rate AVAH

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
RBC Capital MarketsOutperform$10Jun 3, 2026
StephensOverweight$11May 15, 2026
Raymond JamesStrong Buy$13Mar 20, 2026
William BlairOutperformDec 8, 2025

Questions about Raymond James and AVAH

What is Raymond James's price target for AVAH?
Raymond James's latest stated price target for Aveanna Healthcare Holdings Inc. (AVAH) is $13, from its action on Mar 20, 2026.
What is Raymond James's rating on AVAH?
Raymond James rates AVAH Strong Buy, a bullish rating, as of Mar 20, 2026.
When did Raymond James last change its view on AVAH?
On Mar 20, 2026, Raymond James upgrades to Strong Buy from Outperform, price target $13.
How does Raymond James's AVAH target compare with other analysts?
Across 3 firms with a AVAH price target in the last 12 months, the median target is $11. Raymond James's $13 is 18% above that.

All Raymond James ratingsAVAH news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.